In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses

被引:133
作者
Shin, T
Yoshimura, K
Shin, T
Crafton, EB
Tsuchiya, H
Housseau, F
Koseki, H
Schulick, RD
Chen, LP
Pardoll, DM [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21231 USA
[3] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan
关键词
D O I
10.1084/jem.20050072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B7-DC, one of the recently described B7 family members, has the capacity to inhibit T cell responses via engagement of the immunoreceptor tyrosine-based inhibitory motif-containing inhibitory PD-1 receptor as well as enhance responses via an as yet unidentified costimulatory receptor. B7-DC is highly homologous to a coinhibitory B7 family member, B7-H1, which also binds PD-1. It is currently unclear which B7-DC function-costimulation or inhibition predominates in vivo. To study in vivo functions of B7-DC, we evaluated immune responses in B7-DC knockout (KO) mice. Although not eliminated, interferon-gamma (IFN-gamma) production by CD4 T cells and IFN-gamma-dependent humoral responses were reduced in B7-DC KO mice relative to wild type mice. Antigen-specific CD8 T cell responses and cytotoxic T lymphocyte (CTL) activity were also diminished in B7-DC KO mice. Hepatic tumors grew more quickly in B7-DC KO mice, associated with a decrease in intrahepatic tumor-specific CD8 T cells. These results highlight the contrasting in vivo roles of B7-DC and B7-H1 and indicate that B7-DC functions as a tuning molecule, selectively augmenting T helper 1 and CTL responses.
引用
收藏
页码:1531 / 1541
页数:11
相关论文
共 35 条
  • [1] The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
    Ansari, MJI
    Salama, AD
    Chitnis, T
    Smith, RN
    Yagita, H
    Akiba, H
    Yamazaki, T
    Azuma, M
    Iwai, H
    Khoury, SJ
    Auchincloss, H
    Sayegh, MH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) : 63 - 69
  • [2] Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO
  • [3] 2-9
  • [4] Costimulatory regulation of T cell function
    Chambers, CA
    Allison, JP
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 203 - 210
  • [5] CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy
    Chambers, CA
    Kuhns, MS
    Egen, JG
    Allison, JP
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 565 - 594
  • [6] Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity
    Chen, LP
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (05) : 336 - 347
  • [7] B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes
    Dong, HD
    Zhu, GF
    Tamada, K
    Flies, DB
    van Deursen, JMA
    Chen, LP
    [J]. IMMUNITY, 2004, 20 (03) : 327 - 336
  • [8] Dong HD, 1999, NAT MED, V5, P1365
  • [9] Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
  • [10] Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
    Freeman, GJ
    Long, AJ
    Iwai, Y
    Bourque, K
    Chernova, T
    Nishimura, H
    Fitz, LJ
    Malenkovich, N
    Okazaki, T
    Byrne, MC
    Horton, HF
    Fouser, L
    Carter, L
    Ling, V
    Bowman, MR
    Carreno, BM
    Collins, M
    Wood, CR
    Honjo, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) : 1027 - 1034